Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.
about
Immunotherapy for tularemiaIdentification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infectionTularemia vaccines: recent developments and remaining hurdles.Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemiaHost-pathogen interactions and immune evasion strategies in Francisella tularensis pathogenicityLow dose vaccination with attenuated Francisella tularensis strain SchuS4 mutants protects against tularemia independent of the route of vaccination.Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.TLR4-dependent activation of inflammatory cytokine response in macrophages by Francisella elongation factor Tu.Alternative activation of macrophages and induction of arginase are not components of pathogenesis mediated by Francisella speciesB1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses.Tularemia vaccine development: paralysis or progress?Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS)Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensisHematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.
P2860
Q26864945-AD2F0CCA-C5CC-4A96-AB3D-1954AC928DC6Q33788322-EAAD4DDE-FE3B-4ACD-8184-0D3CA12B872AQ33822265-182CBEDA-79C0-4C6A-8B6B-E0243CE4E54FQ34180914-DE210716-2C1D-4439-BFA3-6F2FD3F7153EQ34200786-FA7A44F3-A50A-425D-B754-74130A2E485FQ34237666-6652D40C-798D-45A0-8D0F-60C1213FBB2AQ34291236-8DBD405D-A570-4E78-8B7B-B56EEA5E7139Q34784967-CC8917ED-B311-42F4-B80F-25A6E8162823Q35019458-CD6B5D59-0305-44FC-8B54-F81A42394E02Q35064098-29D7F013-6490-4561-89D8-EA2DEBEACF4BQ36675682-498B1842-7789-4481-966B-920235837CB1Q36908692-EECCED81-EE73-4532-9C45-DAC67C6FE4D3Q37714064-DFD0F9DE-288D-4E68-9002-C2EB579B1141Q39471468-638647AE-5433-478E-B527-3B3C7AF08F91Q41993864-0C92DEB7-EF2C-4C83-9B55-9B95EF4157E2Q52571082-9C9941FD-8E3E-4ED4-BDDB-006DBDAADEB8
P2860
Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Long lived protection against ...... pheral, not pulmonary, organs.
@ast
Long lived protection against ...... pheral, not pulmonary, organs.
@en
Long lived protection against ...... pheral, not pulmonary, organs.
@nl
type
label
Long lived protection against ...... pheral, not pulmonary, organs.
@ast
Long lived protection against ...... pheral, not pulmonary, organs.
@en
Long lived protection against ...... pheral, not pulmonary, organs.
@nl
prefLabel
Long lived protection against ...... pheral, not pulmonary, organs.
@ast
Long lived protection against ...... pheral, not pulmonary, organs.
@en
Long lived protection against ...... pheral, not pulmonary, organs.
@nl
P2093
P2860
P1433
P1476
Long lived protection against ...... pheral, not pulmonary, organs.
@en
P2093
Catharine M Bosio
Deborah D Crane
Rebecca V Anderson
P2860
P304
P356
10.1016/J.VACCINE.2010.07.072
P407
P577
2010-08-03T00:00:00Z